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Abstract
Purpose To report a case of central retinal artery occlusion
(CRAO) in a patient with biopsy-verified Wegener's
granulomatosis (WG) with positive C-ANCA.
Methods A 55-year-old woman presented with a 3-day
history of acute painless bilateral loss of vision; she also
complained of fever and weight loss. Examination showed
a CRAO in the left eye and angiographically documented
choroidal ischemia in both eyes.
Results The possibility of systemic vasculitis was not kept
in mind until further studies were carried out; methylpred-
nisolone pulse therapy was then started. Renal biopsy
disclosed focal and segmental necrotizing vasculitis of the
medium-sized arteries, supporting the diagnosis of WG,
and cyclophosphamide pulse therapy was administered with
gradual improvement, but there was no visual recovery.
Conclusion CRAO as presenting manifestation of WG, in
the context of retinal vasculitis, is very uncommon, but we
should be aware of WG in the etiology of CRAO. This
report shows the difficulty of diagnosing Wegener's
granulomatosis; it requires a high index of suspicion, and
we should obtain an accurate medical history and repeat
serological and histopathological examinations. It empha-
sizes that inflammation of arteries leads to irreversible
retinal infarction, and visual loss may occur
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Introduction
Signs of central retinal artery occlusion (CRAO) often
herald associated systemic vascular events. There are a
number of ways in which the retinal arteries can become
blocked; the most common is by an embolus. Alternatively,
there may be a sudden narrowing of the vessels due to
atherosclerotic changes, vasculitis, vascular spasm, circula-
tory collapse, dissecting aneurysm, and hypertensive
arterial necrosis [1]. Early recognition and treatment may
preserve eye function. A detailed analysis of disease
associated with the acute visual loss is necessary to
elucidate the cause [2].
We report a case of CRAO being the first manifestation
of Wegener's granulomatosis (WG) developed in the setting
of retinal vasculitis. Besides, renal failure with c-
antineutrophil cytoplasmic antibodies (C-ANCA) and
medium-vessel necrotizing inflammation shown by the
biopsy. Retinal involvement is relatively uncommon,
occurring in approximately 5–12% of patients. Retinal
vascular manifestations range from relatively benign
cotton-wool spots, with or without associated intraretinal
hemorrhages, to more severe vaso-occlusive disease,
including CRAO [3]. WG is a rare, chronic multisystemic
disease, with an annual incidence of ten cases per million
population [4, 5]. More common in Caucasians with a peak
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predilection for affecting the upper and lower respiratory
tracts and kidneys [1, 7] and the eyes; central nervous
system can also be affected [8].
The purpose of this report is to consider WG in the
differential diagnosis of CRAO, although this entity is
rarely encountered as presenting sign of the disease.
Case report
A 55-year-old woman was admitted to our department
with complaints of progressive vision loss in the left eye
over the course of 3 days. The patient reported weight
loss, asthenia, and polyarthralgia with progressive weak-
ness persisting for 2 months. Four weeks earlier, she was
referred to the local hospital because she experienced
persistent fever and increasing shortness of breath that had
not responded to amoxicillin–clavulanate treatment; she
was found to have pneumonia and was empirically treated
with various antibiotics. She also developed an episode of
sudden onset, painless reduced vision in the right eye after
admission. She had presented to the emergency depart-
ment 2 months ago with complaints of fever and cough
with mucopurulent expectoration, and she had been
treated with amoxicillin–clavulanate.
The patient was referred to our Ophthalmology Depart-
ment by the rheumatologist who provided her with further
management. Entering examination revealed no perception
of light in her left eye while the visual acuity (VA) of the
right eye was 20/60. Anterior segment appeared unremark-
able. Intraocular pressure was normal. Dilated fundoscopy
of the left eye demonstrated a cherry-red spot at the macula
with edematous retina, characteristic of CRAO (Fig. 1a).
The right fundus showed a slightly pale retina in the
posterior pole (Fig. 1b). The patient was not able to have
fluorescein angiography and indocyanine green angiogra-
phy due to her bad general conditions. On physical
examination, she was febrile and short of breath; her blood
pressure was also high. Her cardiopulmonary examination
revealed increased sounds at the right lung base. In her
musculoskeletal examination, there was swelling and
sensitivity to palpation in the proximal interphalangeal
joints of the right hand and also upon her shoulders, left
ankle, and knee. Her past medical history included
hypertension and chronic venous insufficiency. The initial
patient workup included complete blood count (showing
anemia, neutrophilic leukocytosis, and thrombocytosis);
biochemistry results showed an erythrocyte sedimentation
rate of 5 mm in the first hour and a CRP higher than 90 mg/
l, a blood urea nitrogen level of 28 mg/dL, and a creatinine
level of 2.5 mg/dL, but normal electrolytes and liver
function. Urinalysis revealed moderate hematuria and mild
pyuria. Chest X-ray was negative for pneumonia (Fig. 2).
Possibility of systemic vasculitis was kept in mind, and
intravenous methyprednisolone pulses were started (three
pulses of 0.5 g each). Fluorescein angiography taken a few
days later disclosed delayed retinal arterial filling in both
eyes and nonperfusion through affected cilioretinal artery in
the left eye and, surprisingly, affected choroidal blood flow
with choroidal filling defect in the posterior pole of the
right eye (Fig. 3a) and in peripheral areas of the left eye
(Fig. 3b), rarely seen in patients with CRAO [9].
Additional blood tests revealed anti-nuclear antibody
titer of 1:40, anti-SSA/Ro-antibody-positive, negative hep-
atitis and HIVantibodies, and also progressively increasing
serum creatinine levels with a creatinine clearance of
18 mL/min. Therefore, the patient developed renal failure.
The diagnosis of WG was supported by strongly positive C-
Fig. 2 Chest X-ray revealing enlarged heart, but neither pleural nor
parenchymal abnormalities
Fig. 1 a Fundus photograph of
the right eye shows a slightly
pale retina in the posterior pole.
b Fundus photograph of the left
eye shows obstruction of the
central retinal artery with yel-
lowish retinal appearance and
characteristic cherry-red spot at
the foveola
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that showed focal and segmental necrotizing vasculitis of
the medium-sized arteries (Fig. 4). Computed tomography
(CT) of the brain and orbits was normal. CT scan of the
chest, abdomen, and pelvis revealed pleural effusion,
perirenal hematoma, and splenic infarction (Fig. 5a, b).
The patient was aggressively treated with cyclophospha-
mide for six consecutive cycles, which resulted in a total
cumulative dose of 6.8 g. Concomitant administration of
corticosteroid (1 mg/kg/day oral prednisone) was used, and
the patient gradually improved with radiographic clearing
of pulmonary abnormalities and normalization of laboratory
studies. To maintain remission, oral azathioprine (2 mg/kg/
day) and prednisone (15 mg/day) were administered and
were then gradually tapered. Two years after diagnosis, VA
remains 20/60 in the right eye with no light perception in
the left eye. The funduscopy shows bilateral optic disc
pallor (Fig. 6a, b). Since then, the patient has been
clinically stable, as seen in the OCT (Fig. 7a, b).
Discussion
What initially appeared to be CRAO was, in fact, an
uncommon manifestation of retinal vasculitis due to WG.
Fig. 4 Kidney biopsy showing a vasculitic process of medium-sized
arteries with central necrosis and surrounding histiocytes
Fig. 3 a Fuorescein angiogra-
phy of the right eye revealing
hypoperfusion of the occluded
choroid in the posterior fundus
and staining of the optic disc in
both eyes. b Fuorescein angiog-
raphy of the left eye revealing
nonperfusion through affected
cilioretinal artery and segmental
filling defect of the peripheral
choroid and staining of the optic
disc in both eyes
Fig. 5 a CT scan of the upper
abdomen at the time of the
biopsy shows pleural effusion
and perirenal hematoma
(arrow). b CT scan of the upper
abdomen shows homogeneous
hypodensity in the spleen
(arrow)
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choroidal ischemia. Iida, Kinyoun, and Mirza have reported
respective cases of WG associated with bilateral choroidal
infarctions [10]. We should consider WG in the differential
diagnosis of patients presenting with CRAO and retinal
vasculitis. Although much progress has been made in
retinal vascular occlusion syndromes, more understanding
is still needed to prevent the sequelae of these blinding
disorders [11]. The mechanism underlying retinal vasculitis
in WG remains unknown; the pathogenesis can be inferred
by vasculitis mediated, in part, by stimulatory autoanti-
bodies (ANCA). This process causes the neutrophils to bind
to endothelium and to release mediators that injure the
vessel wall [7, 12].
WG has rarely been implicated in CRAO, although more
commonly in retinal vasculitis. Ocular manifestations may
represent the first sign of WG, and early diagnosis could
prevent potentially life-threatening renal failure with its
increased morbidity and mortality [13, 14]. In the acute
setting, diagnosis is usually clinical and should include
patient's medical history, review of systems, and ocular
examination. Therefore, a multi-disciplinary approach is
required [15]. Laboratory investigations should be directed
towards suspected diagnosis [16]. Fluorescein angiography
may be helpful and frequently shows that the vasculitis is
more extensive than the clinical examination suggests [17].
An angiographic study showed that retinal vasculitis and
choroidal inflammation develop independently from each
Fig. 6 a Right eye fundus showing a mild pallor of the optic disc. b Left eye fundus showing a marked pallor of the optic disc
Fig. 7 a The OCT of the right eye at final examination shows no macular edema. b The OCT of the left eye at final examination shows no
macular edema
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cyclophosphamide [18].
WG is a rare entity that can affect almost any part of the
body [6]. In fact, WG is diagnosed by the presence of two
of these four criteria established by the American College
of Rheumatology, which includes nasal or oral inflamma-
tion, abnormal chest radiograph, excessive urinary sedi-
ment, and granulomatous inflammation on biopsy [7]. In
WG, 80–95% of cases are C-ANCA (anti-PR3)-positive
[4].
Our case emphasizes that serious visual complications
may occur in WG, and early diagnosis is necessary because
delay in diagnosis is unfortunately common and this often
leads to a worse prognosis [4, 5].
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